Tema Launches Two ETFs Focused on Curing Cancer & Global Royalties

Tema announced the addition of two new actively managed thematic ETFs: the Oncology ETF (CANC) and Global Royalties ETF (ROYA). CEO Maurits Pot weighs in on why oncology is “the biggest biotech megatrend” and ways that global royalties can “deliver equity-like returns with contractually supported income.”